Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/9716356

Eur. J. Pharmacol. 1998 Jul 10 352 2-3 207-14

Download in:

View as

General Info

PMID
9716356